CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.

1:24-cv-00005

Overview

Case Number 1:24-cv-00005
Filing Date 2024-01-03
Status Terminated
Termination Date 2024-09-03
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Samsung Bioepis Co. Ltd. Operating Company

Represented By

7 Attorneys Listed

Orion Armon

Email: oarmon@cooley.com

Michelle S. Rhyu

Email: rhyums@cooley.com

Jonathan R. Davies

Email: jdavies@cooley.com

James L. Higgins

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5034

Rodney Square, 1000 North King Street

Brianna Patterson

Email: bchamberlin@cooley.com

Andrew Colin Mayo

Ashby & Geddes

Tel: +1 (302) 654-1888

Ashby & Geddes, 500 Delaware Avenue, 8th Floor

Plaintiff

Alexion Pharmaceuticals, Inc. Operating Company

Represented By

5 Attorneys Listed

Andrew J. Cochran

Email: acochran@cahill.com

Gerald J. Flattmann , Jr.

Email: gflattmann@cahill.com

Maliheh Zare

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

405 N. King Street, Wilmington, DE 19801

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Counter Defendant

Alexion Pharma International Operations Ltd. Operating Company

Represented By

5 Attorneys Listed

Andrew J. Cochran

Email: acochran@cahill.com

Gerald J. Flattmann , Jr.

Email: gflattmann@cahill.com

Maliheh Zare

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

405 N. King Street, Wilmington, DE 19801

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 10 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (10): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 4
USPTO PTAB Trial 2023-06-16
IPR2023-01070

Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2023-06-16
IPR2023-01069

Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (10590189)
Status: Terminated-Settled
USPTO PTAB Trial 2023-05-18
IPR2023-00933

Samsung Bioepis Co., Ltd. v. Alexion Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (9732149)
Status: Terminated-Settled
USPTO PTAB Trial 2019-02-28
IPR2019-00741

Amgen, Inc. v. Alexion Pharmaceuticals, Inc.

U.S. Continuation Sibling (9732149)
Status: Terminated-Settled
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

6 Patents

There are 6 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9732149
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Filed: 2016-10-03
Issued: 2017-08-15
Active (9.9 yrs remaining)
Expires: 2036-10-03
US9718880
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Filed: 2016-05-06
Issued: 2017-08-01
Active (9.5 yrs remaining)
Expires: 2036-05-06
US9725504
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Filed: 2016-09-09
Issued: 2017-08-08
Active (9.8 yrs remaining)
Expires: 2036-09-09
US10590189
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Filed: 2017-07-05
Issued: 2020-03-17
Active (0.8 yrs remaining)
Expires: 2027-09-08
US10703809
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Filed: 2020-02-28
Issued: 2020-07-07
Active (13.3 yrs remaining)
Expires: 2040-02-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

27

Dispositive

21

Granted

0

Denied

2

Pending / Review

23

Motions by Category

Procedural / Extension Motion 6 Motion for Preliminary Injunction / TRO 21

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
ORAL ORDER: The Court has reviewed Alexion's Emergency Motion for Injunction Pending Appeal (D.I. 60). The motion constitutes a motion for reconsideration with ...
Entry #77 • 2024-06-17 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
[SEALED] REPLY BRIEF re 60 MOTION Emergency Motion for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of this Motion filed by Alex...
Entry #73 • 2024-06-07 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
Unopposed MOTION to Seal Reply Brief in Support of Emergency Motion for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of this Mot...
Entry #71 • 2024-06-06 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 60 MOTION Emergency Motion for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of this Mo...
Entry #68 • 2024-05-31 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
MOTION Emergency Motion for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of this Motion - filed by Alexion Pharma International ...
Entry #60 • 2024-05-17 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
[SEALED] OPENING BRIEF in Support re 60 MOTION Emergency Motion for Injunction Pending Appeal and Temporary Restraining Order Pending Resolution of this Motion ...
Entry #61 • 2024-05-17 Document →

Docket Entries

(122 total)
Pleading / Complaint

COMPLAINT filed against Samsung Bioepis Co. Ltd. ( Filing fee $ 405, receipt number ADEDC-4305458.) - filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd.. (Attachments: # 1 Exhibits A-K, # 2 Civil Cover Sheet)(mpb) (Entered: 01/03/2024)

Entry #1 • 2024-01-03
1
Pleading / Complaint

COMPLAINT filed against Samsung Bioepis Co. Ltd. ( Filing fee $ 405, receipt number ADEDC-4305458.) - filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd.. (Attachments: # 1 Exhibits A-K, # 2 Civil Cover Sheet)(mpb) (Entered: 01/03/2024)

Entry #1 • 2024-01-03
2
Pleading / Complaint

COMPLAINT filed against Samsung Bioepis Co. Ltd. ( Filing fee $ 405, receipt number ADEDC-4305458.) - filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd.. (Attachments: # 1 Exhibits A-K, # 2 Civil Cover Sheet)(mpb) (Entered: 01/03/2024)

Entry #1 • 2024-01-03
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 01/03/2024)

Entry #2 • 2024-01-03
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,732,149; 9,718,880; 9,725,504; 10,590,189; 10,703,809; 9,447,176. (Attachments: # 1 Patent/Trademark Report)(mpb) (Entered: 01/03/2024)

Entry #3 • 2024-01-03
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc